Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Merck
Baxter
Medtronic
US Army
Cantor Fitzgerald
Deloitte
Fuji
Healthtrust

Generated: June 24, 2018

DrugPatentWatch Database Preview

DIAPID Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Diapid patents expire, and when can generic versions of Diapid launch?

Diapid is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in DIAPID is lypressin. Additional details are available on the lypressin profile page.
Summary for DIAPID
Drug patent expirations by year for DIAPID
Medical Subject Heading (MeSH) Categories for DIAPID
Synonyms for DIAPID
(2S)-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5
(2S)-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)1,2-d
(2S)-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)-1,2
(8-Lysine)vasopressin
(Lys8)-Vasopressin
[8-Lysine]vasopressin
[Lys8]-Vasopressin
[Lys8]AVP
076L754
1-[[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)-1,2-dithia-5,8,11,14,17-pentaazacycloeicos-4-y
1-{[(4R,7S,10S,13S,16S,19R)-19-Amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}-L-p rolyl-L-lysylglycinamide
1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane-10-propionamide
19-amino-4-[2-[[5-amino-1-[(carbamoylmethyl)carbamoyl]pentyl]carbamoyl]-1-pyrrolidinylcarbonyl]-13-benzyl-7-(carbamoylmethyl)-16-p-hydroxybenzyl-6,9,12,15,18-pentaoxo- (6CI)
3-(Phenylalanine)-8-lysine oxytocin
50-57-7
7CZF3L922Y
8-L-Lysine vasopressin
8-L-Lysinevasopressin
AC1LD8IK
AKOS030529559
BJFIDCADFRDPIO-DZCXQCEKSA-N
BRD-K93331255-001-01-2
BRN 4648365
C46H65N13O12S2
CAS-50-57-7
CHEBI:94802
CHEMBL1200690
CL-017
CS-5838
Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2[Disulfide Bridge: 1-6]
D09PZZ
DSSTox_CID_28501
DSSTox_GSID_48575
DSSTox_RID_82773
DTXSID8048575
EINECS 200-050-5
FT-0656049
Glycinamide, L-cysteinyl-L-tyrosyl-L-phenylalanyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-lysyl-, cyclic (1>6)-disulfide
GTPL2172
HY-P0004
L-Cysteinyl-L-tyrosyl-L-phenylalanyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-lysylglycinamide cyclic (1->6)-disulfide
L-Cysteinyl-L-tyrosyl-L-phenylalanyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-lysylglycinamide cyclic (1-6)-disulfide
L-lysinamide,
L-Lysine vasopressin
l]carbonyl]-L-prolyl-N-(2-amino-2-oxoethyl)-
Lipresina
Lipresina [INN-Spanish]
Lipressina
Lipressina [DCIT]
LVP
LYPRESSIN
Lypressin [USAN:USP:INN:BAN]
Lypressine
Lypressine [INN-French]
Lypressinum
Lypressinum [INN-Latin]
Lysine pitressin
Lysine vasopressin
Lysine-8-vasopressin
Lysine-ADH
Lysine-vasopressin
Lysipressin
Lysipressin acetate
Lysopressin
Lysylvasopressin
MFCD00076754
NCGC00181743-01
NCGC00181743-02
Oxytocin, 3-(L-phenylalanine)-8-L-lysine-
Postacton
SCHEMBL33287
Syntopressin
Tox21_112902
Tox21_113427
UNII-7CZF3L922Y
Vasopressin (lysine form)
Vasopressin-8-lysine
Vasopressin, 8-L-lysine-
Vasopressin, 8-L-lysine- (7CI,8CI,9CI)

US Patents and Regulatory Information for DIAPID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis DIAPID lypressin SOLUTION;NASAL 016755-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Accenture
Express Scripts
Teva
Cerilliant
McKinsey
Moodys
Mallinckrodt
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.